Pertussis toxin induced lymphocytosis
US5888726A · kind A · utility
0Cited by
2References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 23, 1997 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Apr 23, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/235
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention involves HIV evaluation and AIDS treatment by eliciting lymphocytosis with pertussis toxin in order to reveal the sequestered HIV or SIV in the lymph tissues enabling HIV infection analysis, viral quantification and treatment. The lymphocytosis itself causes an alleviation of the AIDS symptoms and a reduction in the viral load. The present invention could also be used in conjunction with a large variety of adjunct therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.